Literature DB >> 740192

Cervical and lumbar routes for metrizamide cervical examination.

J F Sackett.   

Abstract

The C1-C2 lateral spinal puncture for metrizamide injection is compared to decubitus lumbar puncture for cervical myelography. By lumbar route, the contrast medium was taken into the cervical region with the patient prone. The instances when the lumbar route could not be used include cervical spinal trauma, spinal deformity, and lumbar epidural infection. Routine metrizamide cervical myelography by the C1-C2 route has better film quality and probably fewer short-term adverse reactions than use of the lumbar route of injection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 740192     DOI: 10.1007/bf00395270

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

1.  Thoracic and cervical myelography with metrizamide. Clinical experiences with a water-soluble, non-ionic contrast medium.

Authors:  I O Skalpe; P Amundsen
Journal:  Radiology       Date:  1975-07       Impact factor: 11.105

2.  Cervical myelography by lateral cervical and lumbar injection of metrizamide. A comparison.

Authors:  O Sortland; I O Skalpe
Journal:  Acta Radiol Suppl       Date:  1977

3.  Lateral cervical puncture for myelography. Technical note.

Authors:  D L Kelly; E Alexander
Journal:  J Neurosurg       Date:  1968-07       Impact factor: 5.115

4.  Percutaneous radiofrequency cervical cordotomy: technique.

Authors:  H L Rosomoff; C J Brown; P Sheptak
Journal:  J Neurosurg       Date:  1965-12       Impact factor: 5.115

5.  Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.

Authors:  J F Sackett; C M Strother; C E Quaglieri; M J Javid; A B Levin; T A Duff
Journal:  Radiology       Date:  1977-06       Impact factor: 11.105

  5 in total
  1 in total

1.  Iopamidol vs metrizamide: a double blind study for cervical myelography.

Authors:  B P Drayer; M A Warner; A Sudilovsky; J Luther; R Wilkins; S Allen; M Bates
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.